Affective disorders and endocrine disease. New insights from psychosomatic studies (Q40702091)

22 September 2017

1 reference

title

Affective disorders and endocrine disease. New insights from psychosomatic studies (English)

1 reference

22 September 2017

Fava GA

1 reference

22 September 2017

language of work or name

1 reference

1 July 1994

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

341-353

1 reference

Psychosomatic medicine: past and present. Part II. Current state

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

How much longer must medicine's science be bound by a seventeenth century world view?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Prodromal symptoms in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Psychoneuroendocrinology of stress and emotions: issues for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

A review of psychoendocrine research on the pituitary-adrenal cortical system

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Neuropsychiatric aspects of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Cushing's disease as a psychosomatic disorder. A report of ten cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Cushing's syndrome: a psychiatric study of 29 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Stressful life events in the pathogenesis of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

A role for life events in the pathogenesis of Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Physiopathology of Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Life events and depression. A replication

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Stressful life events and Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

The fate of organic mental disorders in DSM-IV: a progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Depression hostility and anxiety in hyperprolactinemic amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Hyperprolactinemia, distress, and hostility

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Effect of bromocriptine on affect and libido in hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Psychological correlates of hyperprolactinemia in males

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Neuropsychiatric presentation of men with pituitary tumors (the 'four A's')

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Postpartum hostility and prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Depression and anxiety associated with secondary amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Hypercortisolism in patients with functional hypothalamic-amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Psychosomatic assessment of hirsute women.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Quality of life of hirsute women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Agoraphobia and hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Phobia as a symptom in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

The metyrapone test in affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pretreated with metyrapone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Pituitary size in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (alpha1-24-corticotropin) in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Steroids and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Effects of metyrapone and dexamethasone upon pro-gamma-MSH plasma levels in depressed patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Beta-endorphin responses to metyrapone and dexamethasone in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Loss of Glucocorticoid Fast Feedback in Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Paradoxical ACTH Response to Glucocorticoids in Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Hypercortisolism and its possible neural bases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

The hypothalamic-pituitary-adrenal cortical axis in mental disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Absence of nocturnal elevation of plasma prolactin concentrations in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Prolactin, amitriptyline, and recovery from depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Nocturnal prolactin and cortisol secretion and recovery from melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Prolactin, cortisol, and antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

The biopsychosocial model and the education of health professionals

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Medical-psychiatric service

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Depressed Mood and Other Psychiatric Manifestations of Cushingʼs Syndrome: Relationship to Hormone Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

The Hamilton Depression Rating Scale in normals and depressives

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

Psychoneuroendocrine strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2894%2971755-2

7 January 2021

10.1016/S0033-3182(94)71755-2

Identifiers

DOI

0 references

1 reference